• Synergistic Hyperthermia-Cisplatin Therapy Triggers Caspase-

  2026-06-11

  This study reveals that combining hyperthermia with cisplatin enhances apoptosis and pyroptosis in cancer cells by promoting caspase-8 accumulation, K63-linked polyubiquitination, and downstream activation of caspase-3. These mechanistic insights offer a foundation for refining combinatorial cancer therapies targeting the caspase signaling pathway.

• TPPU as a Soluble Epoxide Hydrolase Inhibitor in Osteoclasto

  2026-06-11

  TPPU is redefining preclinical workflows as a potent, selective soluble epoxide hydrolase inhibitor, enabling precise modulation of lipid signaling in inflammatory pain and osteoporosis models. This guide translates cutting-edge findings on the hepatic sEH–Nrf2–osteoclastogenesis axis into actionable protocols and troubleshooting tips.

• HyperPFU™ high-fidelity DNA polymerase: Practical PCR Guidan

  2026-06-10

  HyperPFU™ high-fidelity DNA polymerase is designed for PCR amplification of long, GC-rich, or otherwise challenging DNA templates that require high sequence fidelity. It is optimal for workflows where blunt-ended, low-error PCR products are necessary, but it should not be used for applications requiring 3'-A overhangs or sticky-end products.

• Imaging Neuroinflammation in Hepatic Encephalopathy: Bifidob

  2026-06-10

  This study utilizes [18F]PBR146 PET imaging to compare the efficacy of Bifidobacterium and fecal microbiota transplantation in reducing neuroinflammation in a chronic hepatic encephalopathy rat model. The findings highlight Bifidobacterium's capacity to inhibit neuroinflammation, while FMT showed no such effect, underscoring the importance of targeted gut-microbiota interventions for brain health in liver disease.

• ZNF263 Drives ICC Growth by Activating ULK1-Dependent Autoph

  2026-06-09

  This study reveals that zinc finger protein 263 (ZNF263) promotes intrahepatic cholangiocarcinoma (ICC) proliferation by upregulating ULK1 and enhancing autophagy. The findings define a mechanistic link between ZNF263, ULK1-mediated autophagy, and aggressive tumor growth, highlighting ZNF263 as a potential biomarker and therapeutic target.

• 3-Bromopyruvate and Cetuximab: Inducing Ferroptosis to Overc

  2026-06-09

  This study reveals that combining 3-bromopyruvate with cetuximab overcomes both intrinsic and acquired resistance in colorectal cancer cells by inducing autophagy-dependent ferroptosis and apoptosis. Mechanistic insights into FOXO3a pathway reactivation provide a new strategy for addressing therapeutic resistance in metastatic colorectal cancer.

• 5-Azacytidine-Induced Dormancy Suppresses Metastasis via TGF

  2026-06-08

  Singh et al. (2023) demonstrate that combining 5-Azacytidine with retinoic acid reprograms disseminated cancer cells (DCCs) into a stable dormant state, significantly suppressing metastatic outgrowth via restoration of TGF-β-SMAD4 signaling. This mechanistic insight highlights a promising epigenetic approach to delay or prevent metastasis, with direct implications for experimental models of cancer dormancy.

• DiscoveryProbe Bioactive Compound Library Plus: High-Through

  2026-06-08

  The DiscoveryProbe Bioactive Compound Library Plus (SKU: L1022P) revolutionizes high-throughput ligand screening with 5,072 rigorously validated, cell-permeable compounds. Its pre-dissolved format and targeted diversity accelerate apoptosis assays and pathway-focused research, while robust data support enables troubleshooting and protocol optimization for advanced discovery workflows.

• Sisomicin in Antibacterial Testing: Protocols, Applications,

  2026-06-07

  Sisomicin, a potent aminoglycoside antibiotic, empowers researchers to design robust Gram-negative and Gram-positive infection models. This article delivers actionable workflows, troubleshooting guidance, and data-driven insights for maximizing the utility of Sisomicin in modern antibacterial research.

• ECL Western Blotting Substrate: Technical Use and Best Pract

  2026-06-06

  ECL Western Blotting Substrate (SKU K2187) is designed to enhance protein detection by chemiluminescence in Western blot assays, particularly for horseradish peroxidase-conjugated targets. It addresses the need for high-sensitivity, nonradioactive detection in research areas such as molecular biology and cancer biology, but should not be used for fluorescent or radioisotopic workflows.

• Iptacopan (LNP023): Applied Workflows for Complement Pathway

  2026-06-05

  Iptacopan (LNP023) stands out as a highly selective, reversible inhibitor of complement factor B, enabling precise control of the alternative complement pathway in both cellular and animal models. This guide delivers actionable workflow enhancements, advanced troubleshooting, and key innovations for assay design, leveraging APExBIO’s Iptacopan for transformative complement activation research.

• Fosinopril Sodium (SKU A4079): Reliable ACE Inhibition in La

  2026-06-05

  This article addresses core laboratory challenges in cardiovascular and renal research, focusing on reproducibility and protocol optimization when using Fosinopril sodium (SKU A4079). By presenting scenario-driven Q&A, we demonstrate how this third-generation ACE inhibitor supports consistent outcomes in cell viability, proliferation, and cytotoxicity assays.

• Microglial Activation and Seizure Risk in Acute Alcohol Expo

  2026-06-04

  The referenced study uncovers how acute alcohol exposure triggers microglial activation in the hippocampal CA1 region, leading to neuronal dysregulation and increased seizure susceptibility. These findings clarify the mechanism by which microglia modulate synaptic balance, offering new directions for targeting neuroinflammatory pathways in seizure research.

• circRNA hsa_circ_0001944 Modulates FXR/TLR4 and Ferroptosis

  2026-06-04

  This study demonstrates that hsa_circ_0001944 alleviates nickel oxide nanoparticle-induced collagen deposition in hepatic stellate cells by regulating the FXR/TLR4 pathway and ferroptosis. The findings provide new mechanistic insight into non-coding RNA-mediated modulation of nuclear receptor signaling and cell death in liver fibrosis, advancing the field's understanding of nanoparticle hepatotoxicity.

• MMP7 Drives EMT-Linked Liver Fibrosis via E-cadherin/β-Caten

  2026-06-03

  This study elucidates how matrix metalloproteinase 7 (MMP7) accelerates liver fibrosis in biliary atresia by promoting epithelial–mesenchymal transition (EMT) via E-cadherin cleavage and β-catenin signaling activation. The findings highlight MMP7 as a mechanistic and potentially therapeutic target for progressive fibrosis in this pediatric disease.

16884 records 1/1126 page Next 12345 下5页 Last page